The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM and Interim Mana

29 Aug 2008 15:20

RNS Number : 3527C
Marchpole Holdings PLC
29 August 2008
 



 

Marchpole Holdings plc 

("Marchpole" or "the Group")

Result of General Meeting and Interim Management Statement

Marchpole (LSE: MPH) announces that all of the resolutions which were put to today's General Meeting ("GM") were duly passed. Details of the resolutions, which included resolutions relating to the placing of 1,360,000 new Ordinary Shares at 11.5p per share and issue of £2,343,600 convertible loan notes (the "Loan Notes") to Atlas Design AB, were set out in a circular to Marchpole shareholders dated 6 August 2008.

A proportion of the Loan Notes have, on passing of the resolutions at the GM, converted into 1,374,000 new Ordinary Shares ("Part Conversion Shares") at a price of 11.5p per share. An application has been made to the UK Listing Authority and the London Stock Exchange plc for the Part Conversion Shares to be admitted to the Official List and to trading on the London Stock Exchange (respectively). It is expected that admission will take place and that trading will commence in the Part Conversion Shares on 5 September 2008.

The total number of shares in issue and therefore the total number of voting rights following the issue of new shares will be 30,076,912. This figure may be used by Marchpole shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest, or change to the interest in, Marchpole, under the FSA's Disclosure and Transparency Rules.

Copies of the resolutions passed at the GM have been submitted to the UK Listing Authority and will be available shortly for inspection at the UK Listing Authority's Document Viewing Facility which is situated at:

Financial Services Authority

25 The North ColonnadeCanary WharfLondon

E14 5HS

Tel: 020 7676 1000

Marchpole also announces its Interim Management Statement in compliance with the EU's Transparency Directive. The statement relates to the period from 6 April 2008 to date. There has been no material change in the financial position of the Group during the period (save as announced to the market) and trading has been consistent with the Board's expectations in the prevailing difficult market conditionsThe Directors believe that these conditions will remain difficult for the remainder of six month period to 30 September 2008.

Press enquiries:

Marchpole Holdings plc 020 7908 7777

Michael Morris, Executive Deputy Chairman

Bell Pottinger Corporate & Financial 020 7861 3232

David Rydell / Emma Kent / Amy Rajendran

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEMFLUSASEFA
Date   Source Headline
15th Dec 20206:22 pmRNSAIM Delisting
30th Nov 20207:00 amRNSKey Dates for AIM Delisting
23rd Nov 202012:00 pmRNSMereo appoints Suba Krishnan
16th Nov 202012:00 pmRNSVirtual R&D Day
11th Nov 20207:00 amRNSCancellation of AIM admission
10th Nov 202012:00 pmRNSStifel 2020 Virtual Healthcare Conference
20th Oct 202012:00 pmRNSAppointments of CFO and SVP
19th Oct 202012:00 pmRNSTIGIT IND FDA Clearance
12th Oct 20201:44 pmRNSPDMR Notification
9th Oct 20204:05 pmRNSDirector/PDMR Shareholding
7th Oct 202012:00 pmRNSRegistration Statement Filed with US SEC
29th Sep 202012:00 pmRNSInterim Results for 6 months ended June 30, 2020
28th Sep 20203:21 pmRNSResult of General Meeting
28th Sep 202012:00 pmRNSChanges to Board of Directors
24th Sep 202012:00 pmRNSFDA Rare Pediatric Disease Designation
16th Sep 20201:00 pmRNSNotice of Interim Results
4th Sep 20207:00 amRNSNotice of General Meeting
25th Aug 202012:00 pmRNSInitiation of COVID-19 Respiratory Disease Trial
14th Aug 20207:00 amRNSPDMR Notification
13th Aug 20207:00 amRNSNotification of PDMR Dealing
6th Aug 20207:00 amRNSAppointment of Nominated Adviser & Broker
5th Aug 20207:00 amRNSDirector Dealing
6th Jul 20203:59 pmRNSHolding(s) in Company
6th Jul 20209:34 amRNSBlock Listing Application
30th Jun 20201:39 pmRNSResult of General Meeting
30th Jun 202012:00 pmRNSCSO and SVP appointments
29th Jun 20203:56 pmRNSResult of Annual General Meeting
22nd Jun 20204:33 pmRNSHolding(s) in Company
22nd Jun 202011:06 amRNSSecond Price Monitoring Extn
22nd Jun 202011:00 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSFinal Results for the year ended December 31, 2019
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20205:30 pmRNSHolding(s) in Company
9th Jun 20204:45 pmRNSNotice of General Meeting
8th Jun 20205:56 pmRNSHolding(s) in Company
8th Jun 20205:18 pmRNSHolding(s) in Company
8th Jun 20203:20 pmRNSHolding(s) in Company
5th Jun 20203:55 pmRNSHolding(s) in Company
5th Jun 202012:49 pmRNSHolding(s) in Company
4th Jun 20202:05 pmRNSSecond Price Monitoring Extn
4th Jun 20202:00 pmRNSPrice Monitoring Extension
4th Jun 20207:00 amRNSCompletion of $70 Million Private Placement
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
27th May 202012:00 pmRNSNotice of Annual General Meeting
22nd May 202012:00 pmRNSAnnual General Meeting
21st May 20204:18 pmRNSHolding(s) in Company
27th Mar 202012:00 pmRNSBusiness Update and Directorate Change
6th Mar 20207:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.